The Company is a Korea-based company primarily engaged in the biological drug development business. The Company is primarily engaged in the bio-innovative new drug research and development (R D) business such as antibody therapeutics and long-acting recombinant protein pharmaceuticals. The Company was established on January 30, 2013. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on July 28, 2022.
Headquarters
602 Building B, Medical And Bioscience College, Gangwon University 1, Gangwon-Daehakgil
Chuncheon; Gangwon;
Contact Details: Purchase the April Bio Co.,Ltd report to view the information.
Website: http://www.aprilbio.com/
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service